Skip to Main Content
Text size: SmallMediumLargeExtra-Large

NIDCR to Host Autotherapies Symposium on January 25, 2018

What

Image of three green circular arrows next a digitized person.


NIDCR will host a symposium, “Autotherapies: Enhancing Our Innate Healing Capacity,” on January 25, 2018, from 8:00 a.m. to 12:00 p.m. in the Lipsett Amphitheater (Building 10) on the NIH campus. 

Autotherapies are treatments based on the body’s natural ability to heal and protect itself. For example, immunotherapy harnesses the body’s immune cells to fight cancer and is now in clinical use. In the dental, oral, and craniofacial region, autotherapies could be used to selectively signal the body to repair and regenerate tissue, trigger immune responses, and restore a natural microbial balance. These strategies might also help to heal damaged or diseased tissues in other parts of the body, prevent or treat infections, fight cancer, treat autoimmune conditions, and enhance overall health.

Advancing the development of autotherapies is one of the five goals of NIDCR 2030–NIDCR’s vision for the future of dental, oral, and craniofacial research.

 

Who

Image of Martha Somerman, DDS, PhD

8:00 – 8:10 am

Welcome and Introduction

Martha Somerman, DDS, PhD
Director, National Institute of Dental and Craniofacial Research

Image of Lawrence Tabak, DDS, PhD

8:10 – 8:40 am

Opening Remarks and Overview

Lawrence Tabak, DDS, PhD
NIH Principal Deputy Director

Featured Speakers

Image of Jeffrey Karp, PhD 

8:40 – 9:20 am

Stories from Bioinspiration to Innovation

Jeffrey Karp, PhD
Associate Professor, Brigham & Women’s Hospital, Harvard Medical School
Principal Faculty, Harvard Stem Cell Institute

Image of Janice Lee, MD, DDS, MS 

9:20 – 10:00 am

Conceptualizing Clinical Autotherapies for Repair of Craniofacial Abnormalities

Janice Lee, MD, DDS, MS
Clinical Director and Chief, Craniofacial Anomalies and Regeneration Section
National Institute of Dental and Craniofacial Research

 

10:00 – 10:10 am
Break

Image of Edward Botchwey, PhD  

10:10 – 10:50 am

Biomaterials to Re-engineer Immune Response and Enhance Regenerative Capacity of Musculoskeletal Tissues

Edward Botchwey, PhD
Associate Professor, Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University
Director, Laboratory for Immuno-Regenerative Engineering, Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech

Robert Ferris, MD, PhD  

10:50 – 11:30 am

Mechanisms of Response and Resistance to Cancer Immunotherapy

Robert Ferris, MD, PhD
Hillman Professor of Oncology and Director of the Hillman Cancer Center
University of Pittsburgh Medical Center

 

11:30 am – 12 noon
Questions and Answers, Panel Discussion, Closing


When

Thursday, January 25, 2018, 8:00 a.m. to 12:00 p.m.


Where

Lipsett Amphitheater, Clinical Center (Building 10), NIH Campus, Bethesda, Md. View NIH Campus Visitor Information.


Event Resources

  • The January 25 symposium is free and open to the public; no registration is required.
  • Sign language interpretation is available upon request. Individuals who need sign language interpretation, or other accommodations, should contact Mary Daum at Mary.Daum@nih.gov or 301-594-7559. 
  • The symposium will be videocast live and archived. 
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Share This Page

GooglePlusExternal link – please review our disclaimer

LinkedInExternal link – please review our disclaimer

Print

This page last updated: January 05, 2018